Hubei Provincial Bafeng Pharmaceuticals & Chemicals Share Co., Ltd

Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. (hereinafter referred to as "Bafeng pharmaceutical" or "the company") was established in 1997, which is a national key high-tech enterprise and has become one of the largest medical amino acid Industrialization Bases in China. The company’s business scope includes Amino Acid APIs, Amino Acid Preparations, and Amino Acid Derivatives.

Bafeng Pharma Joined Grand Pharmaceutical (China) Co., Ltd. in 2022, and together with Wuhan Grand Hoyo Co., Ltd., it became the core enterprise of its amino acid sector in the field of biotechnology; The amino acid API registration numbers in the Amino Acids plate ranks first in China, taking the lead in the same industry to create and complete a One-stop Service mode with wide coverage of all varieties.

Bafeng Pharma adheres to the development strategy of "Invigorating Enterprises through Science and Technology". It has established a Postdoctoral Scientific Research Workstation, a Postdoctoral Industrial Base, and Hubei Amino Acid Technology Center. It has established a long-term IUR(Industry-University-Research) cooperation relationship with the Institute of Microbiology of the Chinese Academy of Sciences, Wuhan University and other scientific research institutes. The overall technical level of the company is leading in China. It has undertaken more than 20 national and Hubei science and technology research projects, and won the first prize of Hubei Science and Technology Progress and the certificate of Major Scientific and Technological Achievements in Hubei Province. Among them, the construction and immobilization technology of GLYA gene engineering bacteria filled the international blank, and the separation technology of amino acid acylase filled the domestic blank.

• We pursue the quality policy “Quality First, Consumer First” .

• Quality management organization, complete quality monitor network and high efficiency after-sales service system are set.

• Quality management system is being improved constantly.

Under production department: 1st, 2nd, 3rd, 5th and 6th plants and power engineering equipment branch.

In 2015, New drug production lines are constructed. Quality management system is being established and improved so as to get new GMP certificate.

The new production lines are designed by Sinopharm Group United Engineering Co.

The equipment layout and flow chart are referenced from Ajinomoto and Shanghai Kyowa Amino Acid Co., Ltd. Automatic degree of production is high and easy for operation and quality control. Annual capacity: 3000tons

Construction of quality system is strengthened by formulating quality target, supply necessary resources, reasonable plan, organization and coordination. The purpose is to make sure the certification can be realized smoothly and improve quality system constantly.

Our products have been widely used in medicine, food, feed, agriculture, chemical industry, cosmetics, scientific research and so on.